Cryoport Systems and Gulf Coast Regional Blood Center Forge Alliance to Advance Cellular Therapy

Cryoport Systems and Gulf Coast Regional Blood Center Forge Alliance to Advance Cellular Therapy

On October 22, 2024, Cryoport Systems and Gulf Coast Regional Blood Center (GCRBC) announced an exciting new partnership designed to advance cellular therapy services and make critical resources more accessible to the life sciences industry. This strategic alliance brings together the unique capabilities of each organization, resulting in a seamless and efficient solution that supports cellular therapy research, development, and treatment.

The timing of this partnership is significant, as it aligns with the grand opening of the Cryoport Systems IntegriCell™ cryopreservation facility on its Houston campus. This new site serves as a comprehensive resource for cryopreservation, ensuring the highest quality standards in cellular material processing. The partnership is further strengthened by GCRBC's Cellular Life Solutions (CLS) program, which recruits and manages allogeneic donors and handles specialized apheresis collections. Located only two miles from the Cryoport Systems facility, the proximity of CLS to the IntegriCell™ cryopreservation site enables rapid transport of leukopaks-essential cellular materials used in therapies-via specialized Cryoshuttle® transportation service from Cryoport Systems.

Key Benefits of This Partnership for Cellular Therapy

1. Enhanced Quality and Consistency in Cellular Materials - By integrating GCRBC's expertise in donor recruitment and leukopak collection with Cryoport Systems' state-of-the-art cryopreservation and logistics solutions, this alliance addresses a critical need for high-quality, standardized, and manufacture-ready materials in cell a therapy. This combination supports greater consistency and quality, helping reduce variability in cellular therapies and creating a stronger foundation for reliable treatment outcomes.

1. Streamlined Supply Chain for Faster Therapies - Cryoport Systems' and GCRBC's strategic proximity allows for the efficient collection, preservation, and transport of leukopaks within the Houston area, creating an end-to-end solution that accelerates the availability of vital cellular materials. Cryoport's Cryoshuttle® transportation ensures temperature-controlled, near real-time tracked deliveries, crucial for maintaining cellular viability throughout the supply chain.

1. A Foundation for Next-Generation Therapies - This partnership provides a robust infrastructure that will drive the commercialization of cell therapies, facilitating greater access to high-quality starting materials for manufacturers and researchers. By solving a key industry challenge in the collection and cryopreservation of allogeneic leukopaks, Cryoport and GCRBC are directly contributing to the development and accessibility of advanced treatments with transformative potential for patients worldwide.

This partnership marks a new chapter in Cryoport Systems' commitment to supporting the cell and gene therapy ecosystem and advancing the future of medicine. For more details on the alliance, see the full press release.